Search Constraints
« Previous |
1 - 20 of 85
|
Next »
Search Results
Select an image to start the slideshow
Development of the C-methyltransferases NovO and CouO for biocatalytic Friedel-Crafts alkylation
1 of 20
The design, synthesis and optimisation of kinase inhibitors as potential anti-inflammatory agents
2 of 20
Studies and improvement of molecular docking methods in rigid and flexible receptors
3 of 20
Mechanistic pharmacokinetic / pharmacodynamic modelling of acute inflammatory challenge models
4 of 20
Effects of OGG1 activation on mitochondrial function in response to oxidative stress
5 of 20
Development of novel inhibitors of carbohydrate-processing targets involved in Mycobacterium tuberculosis cell wall biosynthesis
6 of 20
The development of small molecule inhibitors for fibrosis drug discovery
7 of 20
New treatments for inflammatory diseases : optimisation and understanding of key processes
8 of 20
The synthesis & optimisation of irreversible ITK inhibitors as a potential new treatment for severe asthma
9 of 20
Utilisation of rearrangement chemistry in the synthesis of novel fluorinated ring systems : a computational and experimental study
10 of 20
The design, synthesis and optimisation of epigenetic mechanism inhibitors
11 of 20
Automated, quantitative process analysis by NMR
12 of 20
New methods for the construction of selectively difluorinated carbocycles
13 of 20
Approaches to lead generation for idiopathic pulmonary fibrosis targets
14 of 20
The design, synthesis and optimisation of CCR4 antagonists for the treatment of asthma
15 of 20
Single electron transfer in organic synthesis targeted towards sustainable manufacture
16 of 20
The interplay of multiple ADME mechanisms : prediction of hepatic drug-drug interactions from in vitro
17 of 20
The design, synthesis and optimisation of phosphoinositide-3-kinase (PI3K) inhibitors as potential anti-inflammatory agents
18 of 20
Sustainable cross-couplings for pharmaceutical scale-up using aryldiazonium salts
19 of 20
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
20 of 20